What is the recommended dose of Eliquis (apixaban) for a patient with Deep Vein Thrombosis (DVT) who has started Eliquis taper?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Apixaban Dosing for DVT Treatment

For a patient with DVT starting Eliquis (apixaban), initiate 10 mg orally twice daily for 7 days, then reduce to 5 mg orally twice daily for at least 3 months. 1, 2, 3

Initial Treatment Phase (Days 1-7)

  • Start with 10 mg orally twice daily for the first 7 days as the loading dose regimen to achieve rapid anticoagulation 1, 2, 3
  • No initial parenteral anticoagulation (heparin or LMWH) is required before starting apixaban, unlike warfarin or edoxaban 2
  • This loading dose was validated in the AMPLIFY trial, demonstrating non-inferiority to conventional enoxaparin/warfarin therapy with significantly lower major bleeding rates (0.6% vs 1.8%) 1, 2

Maintenance Phase (Day 8 onwards)

  • After 7 days, reduce to 5 mg orally twice daily 1, 2, 3
  • Continue this dose for at least 3 months for provoked DVT 2
  • For unprovoked DVT or patients with ongoing risk factors, consider treatment duration beyond 3 months 2

Extended Treatment Phase (After 6 months)

If extended anticoagulation is indicated after completing at least 6 months of treatment:

  • Reduce to 2.5 mg orally twice daily for secondary prevention 4, 2, 3
  • This reduced dose minimizes bleeding risk while maintaining efficacy for preventing recurrent DVT 2
  • The 2021 CHEST guidelines suggest using reduced-dose apixaban over full-dose for extended-phase anticoagulation 4
  • Extended-phase anticoagulation does not have a predefined stop date but should be reevaluated at least annually 4

Critical Dosing Considerations

Renal Impairment

  • Avoid apixaban in severe renal impairment (CrCl <15 mL/min) 1, 2
  • Use caution with CrCl <25 mL/min 2

Hepatic Impairment

  • Avoid in significant hepatic impairment (transaminases >2x upper limit of normal or total bilirubin >1.5x upper limit of normal) 2

Missed Dose

  • If a dose is missed, take it as soon as possible on the same day and resume twice-daily administration 3
  • Do not double the dose to make up for a missed dose 3

Common Pitfalls to Avoid

  • Do not use initial parenteral anticoagulation (heparin/LMWH) before starting apixaban—this is a key advantage over warfarin and edoxaban 2
  • Do not skip the 7-day loading phase at 10 mg twice daily; jumping directly to 5 mg twice daily is inadequate for acute DVT treatment 1, 3
  • Do not continue 10 mg twice daily beyond 7 days for standard DVT treatment; this increases bleeding risk without additional benefit 3
  • Routine laboratory monitoring (PT/INR, aPTT) is not required or useful for apixaban dosing adjustments 1

References

Guideline

Apixaban Dosing for Deep Vein Thrombosis Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Apixaban Dosing for Chronic DVT

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.